Global Pet Medicine Market Size & Outlook, 2026-2033

The global pet medicine market size was estimated at USD 14,488.5 million in 2025 and is projected to reach USD 32,805.2 million by 2033, growing at a CAGR of 10.9% from 2026 to 2033.
Revenue, 2025 (US$M)
$14,488.5
Forecast, 2033 (US$M)
$32,805.2
CAGR, 2026 - 2033
10.9%
Report Coverage
Worldwide

Global pet medicine market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Global pet medicine market highlights

  • The global pet medicine market generated a revenue of USD 14,488.5 million in 2025 and is expected to reach USD 32,805.2 million by 2033.
  • The market is expected to grow at a CAGR (2026 - 2033) of 10.9% by 2033.
  • In terms of segment, pharmaceuticals accounted for a revenue of USD 9,335.3 million in 2025.
  • Biologics is the most lucrative product segment registering the fastest growth during the forecast period.
  • In terms of region, North America was the largest revenue generating market in 2025.
  • Country-wise, India is expected to register the highest CAGR from 2026 to 2033.

Global data book summary

Market revenue in 2025USD 14,488.5 million
Market revenue in 2033USD 32,805.2 million
Growth rate10.9% (CAGR from 2026 to 2033)
Largest segmentPharmaceuticals
Fastest growing segmentBiologics
Historical data covered2021 - 2024
Base year for estimation2025
Forecast period covered2026 - 2033
Quantitative unitsRevenue in USD million
Market segmentationBiologics, Pharmaceuticals, Medicated Feed Additives

Other key industry trends

  • In terms of revenue, the North America accounted for 38.2% of the global pet medicine market in 2025.
  • By country, the U.S. is projected to lead the global market in terms of revenue in 2033.
  • By country, India is the fastest growing regional market and is projected to reach USD 843.5 million by 2033.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Pet Medicine Market Companies

Name Profile # Employees HQ Website
Bimeda View profile 1001-5000 Dublin, Dublin, Ireland, Europe https://www.bimeda.com/
Biogenesis Bago View profile 501-1000 Garín, Buenos Aires, Argentina, South America https://www.biogenesisbago.com/en/
Phibro Animal Health Corp Class A View profile 1920 300 Frank W. Burr Boulevard, Suite 21, 3rd Floor, Glenpointe Centre East, Teaneck, NJ, United States, 07666-6712 https://www.pahc.com
Ceva Santé Animale View profile 5001-10000 Libourne, Aquitaine, France, Europe https://www.ceva.us
Dechra Pharmaceuticals View profile 501-1000 Northwich, Cheshire, United Kingdom, Europe http://www.dechra.com
Boehringer Ingelheim View profile 10001+ Ingelheim Am Rhein, Rheinland-Pfalz, Germany, Europe https://www.boehringer-ingelheim.com/
Elanco Animal Health Inc View profile 9800 2500 Innovation Way, Greenfield, IN, United States, 46140 https://www.elanco.com
Merck & Co Inc View profile 72000 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 https://www.merck.com
Virbac SA View profile 5400 2065m LID, 1 ere avenue, Carros, France, 06516 https://www.virbac.com
Zoetis Inc Class A View profile 14100 10 Sylvan Way, Parsippany, NJ, United States, 07054 https://www.zoetis.com

Global pet medicine market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pet medicine market will help companies and investors design strategic landscapes.


Pharmaceuticals was the largest segment with a revenue share of 64.43% in 2025. Horizon Databook has segmented the Global pet medicine market based on biologics, pharmaceuticals, medicated feed additives covering the revenue growth of each sub-segment from 2021 to 2033.


  • Global Pet Medicine Product Outlook (Revenue, USD Million, 2021-2033)
    • Biologics
      • Vaccines
        • Modified/ Attenuated Live
        • Inactivated (Killed)
        • Other Vaccines
      • Other Biologics
    • Pharmaceuticals
      • Parasiticides
      • Anti-infectives
      • Anti-inflammatory
      • Analgesics
      • Others
    • Medicated Feed Additives
  • Global Pet Medicine Pet Outlook (Revenue, USD Million, 2021-2033)
    • Dogs
    • Cats
  • Global Pet Medicine Route of Administration Outlook (Revenue, USD Million, 2021-2033)
    • Oral
    • Injectable
    • Topical
    • Other Routes
  • Global Pet Medicine Drug type Outlook (Revenue, USD Million, 2021-2033)
    • Branded
    • Generics
  • Global Pet Medicine Distribution Channel Outlook (Revenue, USD Million, 2021-2033)
    • Veterinary Hospitals & Clinics
    • E-commerce
    • Offline Retail Stores
    • Others

Reasons to subscribe to Global pet medicine market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Global pet medicine market databook

  • Our clientele includes a mix of pet medicine market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of global-level data and insights on the Global pet medicine market , including forecasts for subscribers. This global databook contains high-level insights into Global pet medicine market from 2021 to 2033, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Global pet medicine market size, by regions, 2021-2033 (US$M)

Top 10 countries: Pet medicine market size, 2025 (US$M)

Global pet medicine market share, by product, 2025 & 2033 (%, US$M)

Pet medicine market: Opportunity assessment by country

Global pet medicine market, by region, 2025 (US$M)

Global pet medicine market size, by regions, 2021-2033 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online